Drug name - Xepi

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6335447 FERRER INTERNACIONAL Quinolonecarboxylic acid derivatives or salts thereof
Nov, 2023

(1 year, 1 month from now)

CN1299356A FERRER INTERNACIONAL Phenanthroquinolizidine Ketone Carboxylic Acid Ramification And Its Salt
Apr, 2019

(3 years ago)

CN1152029C FERRER INTERNACIONAL Phenanthroquinolizidine Ketone Carboxylic Acid Ramification And Its Salt
Apr, 2019

(3 years ago)

IN200000373P2 FERRER INTERNACIONAL Quinolonecarboxylic Acid Derivatives Or Salts Thereof
Apr, 2019

(3 years ago)

IN221166B FERRER INTERNACIONAL Quinolonecarboxylic Acid Derivatives Or Salts Thereof
Apr, 2019

(3 years ago)

EP1070713B1 FERRER INTERNACIONAL Quinolonecarboxylic Acid Derivatives Or Salts Thereof
Apr, 2019

(3 years ago)

EP1070713A1 FERRER INTERNACIONAL Quinolonecarboxylic Acid Derivatives Or Salts Thereof
Apr, 2019

(3 years ago)

EP1070713A4 FERRER INTERNACIONAL Quinolonecarboxylic Acid Derivatives Or Salts Thereof
Apr, 2019

(3 years ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9399014 FERRER INTERNACIONAL Pharmaceutical topical compositions Dec, 2029

(7 years from now)

US9180200 FERRER INTERNACIONAL Pharmaceutical topical compositions Jan, 2032

(9 years from now)

Drugs and Companies using OZENOXACIN ingredient

Treatment: Treatment of impetigo due to staphylococcus aureus or streptococcus pyogenes

Dosage: CREAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
1% CREAM;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.